CytomX Therapeutics Inc - balanço patrimonial (NASDAQ:CTMX) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Total assets 358.66 M339.41 M260.89 M201.79 M120.53 M151.57 M Total liabilities 308.86 M250.03 M346.64 M249.24 M120.99 M52.56 M Total equity 49.8 M89.38 M-85.75 M-47.45 M-456 K99.01 M Total liabilities & shareholders' equities 358.66 M339.41 M260.89 M201.79 M120.53 M151.57 M Total debt —————— Net debt ——————

Notícias

Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last?

Jefferies reitera recomendação de compra para CytomX após dados da fase 1

3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts - TipRanks.com

Piper Sandler eleva preço-alvo das ações da CytomX com base em dados de ensaios clínicos

Jefferies eleva preço-alvo das ações da CytomX após dados de ADC

CytomX precifica oferta de ações de US$ 250 milhões a US$ 5,30 por ação

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

CytomX Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:CTMX) 2026-03-17

CytomX launches $250M public offering to fund drug development

Micron and Intel among market cap stock movers on Monday

CytomX: The Probody Mask Just Slipped, And Investors Like What They See (Upgrade) (CTMX)

Micron, Intel among market cap stock movers on Monday